William Blair Predicts InnovAge’s Q2 Earnings (NASDAQ:INNV)

InnovAge Holding Corp. (NASDAQ:INNV) – Equities researchers at William Blair lowered their Q2 2026 earnings per share estimates for shares of InnovAge in a research report issued on Tuesday, November 4th. William Blair analyst J. Haase now forecasts that the company will post earnings of $0.02 per share for the quarter, down from their prior estimate of $0.04. The consensus estimate for InnovAge’s current full-year earnings is ($0.12) per share. William Blair also issued estimates for InnovAge’s Q3 2026 earnings at $0.03 EPS, Q4 2026 earnings at $0.05 EPS, FY2026 earnings at $0.16 EPS and FY2027 earnings at $0.22 EPS.

InnovAge (NASDAQ:INNV) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.05. The business had revenue of $236.11 million for the quarter, compared to the consensus estimate of $226.64 million. InnovAge had a negative net margin of 1.96% and a negative return on equity of 7.04%. InnovAge has set its FY 2026 guidance at EPS.

A number of other equities research analysts have also recently commented on the company. JPMorgan Chase & Co. started coverage on InnovAge in a report on Thursday, September 18th. They set an “underweight” rating and a $5.00 price target on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of InnovAge in a research note on Wednesday, October 8th. Two analysts have rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell” and an average price target of $5.00.

InnovAge Stock Down 17.6%

INNV opened at $3.99 on Thursday. The stock has a market cap of $541.36 million, a price-to-earnings ratio of -30.69 and a beta of 0.59. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.07 and a current ratio of 1.07. The firm’s fifty day moving average is $4.83 and its 200 day moving average is $4.12. InnovAge has a fifty-two week low of $2.60 and a fifty-two week high of $6.69.

Institutional Investors Weigh In On InnovAge

Several large investors have recently bought and sold shares of the business. Charles Schwab Investment Management Inc. raised its stake in InnovAge by 2.8% during the first quarter. Charles Schwab Investment Management Inc. now owns 164,322 shares of the company’s stock valued at $490,000 after purchasing an additional 4,535 shares in the last quarter. Bank of America Corp DE increased its holdings in shares of InnovAge by 42.4% in the 4th quarter. Bank of America Corp DE now owns 19,945 shares of the company’s stock worth $78,000 after buying an additional 5,936 shares during the last quarter. State of Alaska Department of Revenue purchased a new stake in shares of InnovAge during the 3rd quarter valued at about $33,000. Jane Street Group LLC grew its position in InnovAge by 18.9% in the first quarter. Jane Street Group LLC now owns 46,827 shares of the company’s stock worth $140,000 after acquiring an additional 7,429 shares in the last quarter. Finally, Police & Firemen s Retirement System of New Jersey bought a new stake in InnovAge during the second quarter worth approximately $32,000. Institutional investors own 12.26% of the company’s stock.

InnovAge Company Profile

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.